Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02202577 · ClinicalTrials.gov registry record · NA
Chlorhexidine-Alcohol Versus Povidone-Iodine for Cesarean Antisepsis
A NA study, sponsored by Case Western Reserve University.
- Completed
- Registry status
- NA
- Development phase
- 932
- Enrollment target
NCT02202577: Completed NA study, sponsored by Case Western Reserve University.
NCT02202577 is a NA study that has completed, run by Case Western Reserve University. The registered enrollment target is 932 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02202577, a NA study, has completed, sponsored by Case Western Reserve University.
- COMPLETED
- Registry status
- NA
- Development phase
- 932 participants
- Enrollment target
Study Summary
Primary Hypothesis: chlorhexidine gluconate alcohol skin antiseptic preparation is superior to povidone-iodine scrub and paint skin antiseptic preparation for prevention of cesarean related surgical site infection.
Primary Outcome
Number of Patients with Cesarean-Related surgical site infection by Center for Disease Control (CDC) criteria: superficial, deep, organ space.
Interventions
- DRUG Chlorhexidine - Isopropyl alcohol
- DRUG Povidone-Iodine Scrub and Paint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 932 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT02202577 record still lists
NCT02202577 is an interventional study that assigns participants to a tested intervention. The registered 932 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (34% lower).
The record links to 0 conditions, and to 2 interventions - of which Chlorhexidine - Isopropyl alcohol is the first listed.
NCT02202577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02202577 about?
NCT02202577 is a clinical study titled "Chlorhexidine-Alcohol Versus Povidone-Iodine for Cesarean Antisepsis". Primary Hypothesis: chlorhexidine gluconate alcohol skin antiseptic preparation is superior to povidone-iodine scrub and paint skin antiseptic preparation for prevention of cesarean related surgical site infection.
What is the current status of trial NCT02202577?
This trial is currently completed. It is a NA study. The enrollment target is 932 participants. The study started on 2014-03. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02202577?
The interventions under investigation include: Chlorhexidine - Isopropyl alcohol (DRUG), Povidone-Iodine Scrub and Paint (DRUG).
Who is sponsoring clinical trial NCT02202577?
This trial is sponsored by Case Western Reserve University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02202577's enrollment target sits among peer trials
932 123rd of 2000 higher than 1,878 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04626635 · 933 participants · Phase 1
A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
- NCT05216432 · 930 participants · Phase 1
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- NCT06932029 · 930 participants · NA
SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases
- NCT07235085 · 930 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia